Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
US-Listed Public Company Profile built from SEC and market records · June 2026

Kenvue Inc. (KVUE)

$19.50 -0.36% NYSE: KVUE · 15-min delayed
  • SUMMIT, New Jersey
  • Public · NYSE: KVUE
  • 22,000 employees
$37.0BMarket cap
$15.1BRevenue · FY2025
$1.5BNet income
22,000Employees
KVUENYSE
2023IPO

About Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$15.1B
Net income
$1.5B
Total assets
$27.1B
Market cap
$37.0B

Source: SEC EDGAR · updated Jun 7, 2026

NYSE: KVUE
$19.50 -0.36%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$14.11 $19.88

52-week range

Market cap
$37.0B
Dividend yield
4.31%
Shares outstanding
1.9B
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
May 4, 2023

Kenvue Inc. (KVUE) Stock Price

  • Profitable — net income of $1.5B in FY2025.
  • Trading near its 52-week high.
  • Pays a dividend yielding about 4.31% annually.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

Peers & competitors

No reviews yet. Be the first to review Kenvue Inc..

Write a review
Newsroom

News about Kenvue Inc.

News & sentiment via Polygon.io

FAQ

Kenvue Inc.: frequently asked questions

Is Kenvue Inc. an American company?

Yes — Kenvue Inc. is an American company. Kenvue Inc. is incorporated in Delaware, United States and headquartered in Summit, New Jersey. Its legal-entity record reports no foreign parent — the company is independently American-owned.

Where is Kenvue Inc. incorporated?

Kenvue Inc. is legally incorporated in Delaware, United States, according to its GLEIF legal-entity record.

Who owns Kenvue Inc.?

Kenvue Inc. reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.

Is Kenvue Inc. traded on a US stock exchange?

Yes — Kenvue Inc. trades under the ticker KVUE on the NYSE.

Where is Kenvue Inc. headquartered?

Kenvue Inc. is headquartered in Summit, New Jersey, United States.

Is Kenvue Inc. publicly traded?

Yes — Kenvue Inc. is a publicly traded company. Its stock trades under the ticker symbol KVUE on the NYSE.

What does Kenvue Inc. do?

Kenvue Inc. is an American Cosmetics company in the Health & Beauty sector.

Explore

Similar companies

Browse all →